Atlas Trials

Low-dose Theophylline as Anti-inflammatory Enhancer in Severe Chronic Obstructive Pulmonary Disease

Clinical trial NCT01599871 · COMPLETED

Trial details

NCT number
NCT01599871
Sponsor
Hospital Son Espases
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2011-01-01
Primary completion
2015-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.